mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.003 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.004 |